Literature DB >> 18937990

Factors affecting the quality of voice in the early glottic cancer treated with radiotherapy.

Jai Prakash Agarwal1, Gurmit K Baccher, Chaitali M Waghmare, Indranil Mallick, Sarbani Ghosh-Laskar, Ashwini Budrukkar, Prathamesh Pai, Pankaj Chaturvedi, Anil D'Cruz, Shyam K Shrivastava, Ketayun A Dinshaw.   

Abstract

AIMS: To prospectively analyze the objective voice quality before and after radiotherapy (RT) for early glottic cancer and to evaluate the role of different factors that may affect it.
METHODS: Patients with T1-T2N0M0 glottic cancer underwent voice quality assessment before treatment and after radical RT. Post-RT voice quality was compared to the voice at diagnosis and the voice of healthy individuals used as controls. A comprehensive set of voice parameters were measured. The effects of age, smoking history, T stage, anterior commissure (AC) involvement, radiation dose, fractionation and volumes on pre-treatment and post-treatment voice quality were analyzed.
RESULTS: The voice quality data of 50 patients were analyzed. Following treatment, there was a significant improvement in the majority of measured parameters. However, perturbation and HNR remained inferior compared to controls. A history of smoking, AC involvement and larger RT volumes resulted in poorer voice parameters following RT. There was no significant impact of age alone. T2 tumors had an inferior voice quality before treatment, but did not remain inferior following RT. Hypofractionated RT did not show any negative impact.
CONCLUSIONS: There is a considerable improvement of voice quality following RT. Several factors may have specific effects on pre-treatment and post-treatment voice.

Entities:  

Mesh:

Year:  2008        PMID: 18937990     DOI: 10.1016/j.radonc.2008.09.016

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  9 in total

1.  Hypofractionation vs. conventional radiotherapy fractionation in the conservative treatment of T1 glottic cancer: a prospective cohort study.

Authors:  B G Salas-Salas; D J Domínguez-Nuez; R Cabrera; L Ferrera-Alayón; M Lloret; P C Lara
Journal:  Clin Transl Oncol       Date:  2019-06-01       Impact factor: 3.405

2.  Prospective clinical study on long-term swallowing function and voice quality in advanced head and neck cancer patients treated with concurrent chemoradiotherapy and preventive swallowing exercises.

Authors:  Sophie A C Kraaijenga; Lisette van der Molen; Irene Jacobi; Olga Hamming-Vrieze; Frans J M Hilgers; Michiel W M van den Brekel
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-11-08       Impact factor: 2.503

3.  CO2 laser cordectomy for glottic squamous cell carcinoma involving the anterior commissure: voice and oncologic outcomes.

Authors:  Abie H Mendelsohn; Devora Kiagiadaki; Georges Lawson; Marc Remacle
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-10-29       Impact factor: 2.503

4.  Evaluation of acute/late toxicity and local recurrence in T1-T2 glottic carcinoma treated with accelerated hypofractionated 3D-conformal external beam radiotherapy (3D-CRT).

Authors:  Vassilis E Kouloulias; Anna Zygogianni; Eftychia Mosa; Kalliopi Platoni; John Georgakopoulos; Christos Antypas; Ivelina Beli; Maria Tolia; Paulos Maragoudakis; Ioannis Giotakis; Zisis Papas; Amanda Psyrri; Nikolaos Kelekis; John Kouvaris
Journal:  Radiol Oncol       Date:  2013-05-21       Impact factor: 2.991

5.  Prospective evaluation of voice outcome during the first two years in male patients treated by radiotherapy or laser surgery for T1a glottic carcinoma.

Authors:  Christine D L van Gogh; Irma M Verdonck-de Leeuw; Jeanne Wedler-Peeters; Johannes A Langendijk; Hans F Mahieu
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-02-05       Impact factor: 2.503

Review 6.  Dysphagia, Speech, Voice, and Trismus following Radiotherapy and/or Chemotherapy in Patients with Head and Neck Carcinoma: Review of the Literature.

Authors:  B J Heijnen; R Speyer; B Kertscher; R Cordier; K W J Koetsenruijter; K Swan; H Bogaardt
Journal:  Biomed Res Int       Date:  2016-09-19       Impact factor: 3.411

7.  Voice outcome after unilateral ELS type III or bilateral type II resections for T1-T2 glottic carcinoma: Results after 1 year.

Authors:  Yda van Loon; Martine Hendriksma; Bas J Heijnen; Vivienne A H van de Kamp; Marieke M Hakkesteegt; Stefan Böhringer; Ton P M Langeveld; M A de Jong; W Martin C Klop; Robert J Baatenburg de Jong; Elisabeth V Sjögren
Journal:  Head Neck       Date:  2019-01-16       Impact factor: 3.147

8.  Cost-effectiveness analysis of voice rehabilitation for patients with laryngeal cancer: a randomized controlled study.

Authors:  Mia Johansson; Caterina Finizia; Josefine Persson; Lisa Tuomi
Journal:  Support Care Cancer       Date:  2020-02-20       Impact factor: 3.603

9.  Glottic Malignant Fibrous Histiocytoma: A Case Report and Literature Review.

Authors:  Adham A Aljariri; Abdulrahman R Alsaleh; Hussain A Al-Enazi; Hasan A Haider; Mahir Petkar; Waheed Rahman; Abdulqadir Jeprel Nashwan
Journal:  Case Rep Oncol       Date:  2021-03-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.